E. Yourassowsky
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 54
- Endocrinology top 2%
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing 27
- Microbiology top 5%
- Bacterial Infections and Vaccines 13
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 24
-
- Antibiotics Pharmacokinetics and Efficacy 56
-
- Pneumonia and Respiratory Infections 17
-
- Streptococcal Infections and Treatments 11
-
- Antibiotic Use and Resistance 11
- Co-authors
- W HansenF. CrokaertY. GlupczynskiMark van der LindenM.P. VanderlindenM. LabbéR. VanhoofMartine Labbé
- Journals
- Chemotherapy (17 papers)Journal of Antimicrobial Chemotherapy (15 papers)Antimicrobial Agents and Chemotherapy (13 papers)
- Partner nations
- BelgiumFranceNetherlands
In The Last Decade
E. Yourassowsky
147 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 112
- Molecular Medicine 300
- Endocrinology 171
- Clinical Biochemistry 153
- Microbiology 136
- Infectious Diseases 333
Countries citing papers authored by E. Yourassowsky
This map shows the geographic impact of E. Yourassowsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Yourassowsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Yourassowsky more than expected).
Fields of papers citing papers by E. Yourassowsky
This network shows the impact of papers produced by E. Yourassowsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Yourassowsky. The network helps show where E. Yourassowsky may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Yourassowsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 12 | |
| 2 | 1990 | 8 | |
| 3 | Bactericidal activity of LY-163892, a new cephalosporin, against beta-lactamase-producing strains of Haemophilus influenzae compared with amoxicillin-clavulanic acid | 1989 | 1 |
| 4 | 1989 | 2 | |
| 5 | 1988 | 1 | |
| 6 | A comparative study of the rate of bactericidal activity between netilmicin and piperacillin on Escherichia coli and Pseudomonas aeruginosa | 1987 | 2 |
| 7 | 1987 | 5 | |
| 8 | Effect of subinhibitory concentrations of ketoconazole on Candida albicans measured by radiometric method | 1986 | 1 |
| 9 | Growth curve patterns of Escherichia coli submitted to cefaclor and cephalexin | 1985 | 1 |
| 10 | Activity of cefsulodin against methicillin-resistant Staphylococcus aureus | 1985 | 1 |
| 11 | Recherche de glycosidases chez les Pseudomonas du groupe fluorescent: relation entre sérogroupe et activités glycosidasiques chez P. aeruginosa | 1983 | 5 |
| 12 | Growth curve patterns of Escherichia coli and Pseudomonas aeruginosa exposed to different cefsulodin concentrations | 1982 | 1 |
| 13 | The antimicrobial activity of the cephalosporin CGP 7174/E against Pseudomonas aeruginosa in comparison to carbenicillin, piperacillin and cefotaxime | 1980 | 2 |
| 14 | Haemophilus résistant à l'ampicilline: considérations sur leur mise en évidence et leur incidence dans la région bruxelloise. | 1979 | 1 |
| 15 | Intramuscular piperacillin sodium in uncomplicated lower urinary tract infections: Evaluation of safety, clinical and bacteriological responses and blood levels | 1979 | 1 |
| 16 | [Pseudomonas cepacia hospital infections; uncertainties and experiences with an epidemiological investigation (author's transl)]. | 1979 | 4 |
| 17 | The influence of heparin on the bactericidal activity rate of gentamicin | 1974 | 1 |
| 18 | TRAITEMENT DES INFECTIONS URINAIRES PAR LA PIVAMPICILLINE. EVALUATION CLINIQUE ET MICROBIOLOGIQUE | 1974 | 1 |
| 19 | Septicémies à Bacteroïdes fragilis. Incidence et sensibilité des souches aux antibiotiques. | 1973 | 7 |
| 20 | Effets du chlorure de sodium sur l'acitvité antistaphylococcique de la gentamicine. | 1972 | 1 |
About E. Yourassowsky
E. Yourassowsky is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Clinical Biochemistry, Microbiology and Pharmacology, having authored 170 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (56 papers), Antibiotic Resistance in Bacteria (54 papers), Bacterial Identification and Susceptibility Testing (27 papers), Antimicrobial Resistance in Staphylococcus (24 papers), Pneumonia and Respiratory Infections (17 papers), Bacterial Infections and Vaccines (13 papers), Streptococcal Infections and Treatments (11 papers) and Antibiotic Use and Resistance (11 papers). The work is most often cited by research in Molecular Medicine (300 citations), Endocrinology (171 citations), Clinical Biochemistry (153 citations), Microbiology (136 citations) and Infectious Diseases (333 citations). E. Yourassowsky has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include W Hansen, F. Crokaert, Y. Glupczynski, Mark van der Linden, M.P. Vanderlinden, M. Labbé, R. Vanhoof, Martine Labbé, Sabine Lauwers and J. Freney. Their work appears in journals such as Chemotherapy, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Infection and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.